Straits Times Index
3,307.90 -6.15 (-0.19%) S&P 500
5,318.72 -2.69 (-0.05%) Dow
39,842.24 -30.75 (-0.08%) Nasdaq
16,819.42 -13.21 (-0.08%) Bitcoin USD
70,235.04 +445.51 (+0.64%) CMC Crypto 200
1,521.93 -4.48 (-0.29%)
RYTM Jul 2024 50.000 put
| Previous close | 11.50 |
| Open | 11.50 |
| Bid | 11.50 |
| Ask | 13.90 |
| Strike | 50.00 |
| Expiry date | 2024-07-19 |
| Day's range | 11.50 - 11.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 129 |
GlobeNewswireRhythm Pharmaceuticals Receives Positive Recommendation from NICE for ▼IMCIVREE® (setmelanotide) for Treatment of Obesity and Hyperphagia in Patients with Bardet-Biedl Syndrome
IMCIVREE expected to be funded and available for use in England and Wales within three months through the National Health Service in specialist centresBOSTON, May 22, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced the National Institute for Health and Care Excellence (NICE) has issued guidance that re
- GlobeNewswire
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
BOSTON, May 09, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that on May 6, 2024, the Compensation Committee of Rhythm’s board of directors granted inducement restricted stock units, or RSUs, covering an aggregate of 15,150 shares of its common stock to seven new employees. These inducement RSUs are subjec
Insider MonkeyRhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Q1 2024 Earnings Call Transcript May 7, 2024 Rhythm Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-2.35058 EPS, expectations were $-2.12. Rhythm Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
